Child-Proofing Drugs

When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.

Written byEdyta Zielinska
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

GETTYIMAGES, TOOGA

In 2005, a mother who had just given birth received codeine to dull the pain associated with childbirth. In her body, the codeine was converted into morphine by a drug-metabolizing enzyme called CYP2D6. Although people carry many variations in the gene for this enzyme, this woman had an unusual difference: she expressed multiple copies of the gene. As a result, the additional CYP2D6 enzymes in her body churned through the codeine so efficiently that her morphine levels spiked and stayed high. Unbeknownst to her doctors, high doses of the drug had passed from her milk into her infant. When the baby was brought back to the hospital with gray skin 12 days after his birth, doctors were puzzled. He was an otherwise healthy baby boy. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies